Pfizer triumphs over AstraZeneca in cancer drug patent dispute

Pfizer triumphs over AstraZeneca in cancer drug patent dispute

Published In a landmark ruling, the US District Court for the District of Delaware has ordered AstraZeneca to pay Pfizer $107.5 million in damages for infringing on patents related to the lung cancer drug ‘Tagrisso.’ This case marks a significant victory...
IPRally announces new CEO to lead the next phase of growth

IPRally announces new CEO to lead the next phase of growth

Published IPRally is happy to share some exciting news about a major leadership shift as it gears up for the next phase of its growth journey. Sakari Arvela, co-founder and CEO of IPRally, has decided to transition to the role of Chief Product Officer to further...
The Patent Lawyer - Logo

Subscribe To Our Newsletter

Would you like to receive our popular weekly news alerts straight to your inbox? Solely patent focused and only sent once a week means you can guarantee there will be something you are interested in reading instead of clogging up your inbox with junk. Sign up now!

You have Successfully Subscribed!